Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.37B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 3 |
GE Aerospace
GE
|
+$499M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$344M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$645M |
| 2 |
Lockheed Martin
LMT
|
+$300M |
| 3 |
Xcel Energy
XEL
|
+$292M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Linde
LIN
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 6.01% |
| 4 | Industrials | 5.88% |
| 5 | Consumer Discretionary | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Usana Health Sciences
USNA
$286M
| $286K | ﹤0.01% |
7,961
+2,082
| +35% | +$77.9K |
|
4402
Tenaris
TS
$26.8B
| $285K | ﹤0.01% |
7,553
-4,766
| -39% | -$169K |
|
|
CRGX
4403
DELISTED
CARGO Therapeutics
CRGX
| $285K | ﹤0.01% |
19,740
+4,497
| +30% | +$81.6K |
|
4404
Heartland Express
HTLD
$956M
| $285K | ﹤0.01% |
25,368
+6,821
| +37% | +$80.2K |
|
4405
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.74B
| $284K | ﹤0.01% |
20,281
| – | – |
|
4406
LSI Industries
LYTS
$924M
| $284K | ﹤0.01% |
14,623
+4,525
| +45% | +$84K |
|
4407
Nuvation Bio
NUVB
$2.32B
| $283K | ﹤0.01% |
106,416
+23,178
| +28% | +$59.7K |
|
4408
Movado Group
MOV
$841M
| $283K | ﹤0.01% |
14,372
+2,234
| +18% | +$43.8K |
|
4409
PUT
Bristol-Myers Squibb
BMY
$132B
| $283K | ﹤0.01% |
5,000
| – | – |
|
4410
3D Systems Corp
DDD
$613M
| $283K | ﹤0.01% |
86,159
+16,721
| +24% | +$53.3K |
|
|
MMT
4411
Aberdeen Multi-Market Income Fund
MMT
$243M
| $282K | ﹤0.01% |
60,091
-30,520
| -34% | -$145K |
|
|
INVX
4412
Innovex International
INVX
$1.97B
| $281K | ﹤0.01% |
20,115
+4,350
| +28% | +$65.2K |
|
4413
Consensus Cloud Solutions
CCSI
$647M
| $281K | ﹤0.01% |
11,777
+2,303
| +24% | +$54K |
|
4414
Prime Medicine
PRME
$559M
| $281K | ﹤0.01% |
96,181
-75,287
| -44% | -$264K |
|
4415
Navitas Semiconductor
NVTS
$3.63B
| $279K | ﹤0.01% |
78,149
+16,143
| +26% | +$44.9K |
|
4416
Nano X Imaging
NNOX
$73.8M
| $279K | ﹤0.01% |
38,705
+8,945
| +30% | +$57.3K |
|
|
SRDX
4417
DELISTED
Surmodics
SRDX
| $278K | ﹤0.01% |
7,032
+2,041
| +41% | +$79.4K |
|
4418
South Plains Financial
SPFI
$841M
| $278K | ﹤0.01% |
8,013
+1,506
| +23% | +$54.6K |
|
4419
Immunome
IMNM
$2.83B
| $278K | ﹤0.01% |
26,207
+8,190
| +45% | +$99K |
|
4420
Health Catalyst
HCAT
$128M
| $278K | ﹤0.01% |
39,355
+8,451
| +27% | +$67.3K |
|
|
DFTX
4421
Definium Therapeutics
DFTX
$6.12B
| $278K | ﹤0.01% |
39,974
+15,269
| +62% | +$105K |
|
4422
RCI Hospitality Holdings
RICK
$215M
| $278K | ﹤0.01% |
4,839
+1,333
| +38% | +$65.1K |
|
|
HPP
4423
Hudson Pacific Properties
HPP
$779M
| $277K | ﹤0.01% |
13,044
+2,545
| +24% | +$69.5K |
|
4424
NewtekOne
NEWT
$391M
| $275K | ﹤0.01% |
21,568
+5,444
| +34% | +$73.8K |
|
4425
Goldman Sachs Innovate Equity ETF
GINN
$213M
| $275K | ﹤0.01% |
4,473
| – | – |
|
Similar funds
Wells Fargo's Q4 2024 Portfolio in Review
As of Q4 2024, Wells Fargo held 7,328 positions worth $443B, up 0.37% from $442B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q4 2024 filing shows 529 new, 3,410 increased, 2,105 reduced and 370 closed positions. Its largest new stake was Eaton Vance Total Return Bond ETF: 2,595,720 shares worth $129M. The largest sale was UnitedHealth, an estimated $645M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q4 2024 buy was Eaton Vance Total Return Bond ETF: 2,595,720 shares worth $129M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.37B increase.
- Wells Fargo's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $645M.
- Wells Fargo fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $66M.
- Wells Fargo's ten largest holdings make up 19% of its $443B portfolio in Q4 2024.
- Wells Fargo opened 529 new positions and closed 370 in Q4 2024.
- Wells Fargo's portfolio value rose 0.37% quarter-over-quarter to $443B.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.